Showing results (881-890 of 6,996) with videos related to
Sort By:
Pageof 700
Cancer Science|September 24, 2015
Adjuvant for vaccine immunotherapy of cancer--focusing on Toll-like receptor 2 and 3 agonists for safely enhancing antitumor immunityTsukasa Seya, Hiroaki Shime, Yohei Takeda, et al.Cancer Science|August 25, 2015
Fibrinogen-derived fibrinostatin inhibits tumor growth through anti-angiogenesisChuanke Zhao, Yahui Su, Jianzhi Zhang, et al.Cancer Science|August 28, 2015
Environmental carcinogenesis - 100th anniversary of creating cancerMisa Imai, Okio HinoCancer Science|August 28, 2015
Retinoid X receptor α enhances human cholangiocarcinoma growth through simultaneous activation of Wnt/β-catenin and nuclear factor-κB pathwaysGui-Li Huang, Wei Zhang, Hong-Yue Ren, et al.Cancer Science|October 17, 2015
Phase I trial of volasertib, a Polo-like kinase inhibitor, in Japanese patients with acute myeloid leukemiaYukio Kobayashi, Takahiro Yamauchi, Hitoshi Kiyoi, et al.Cancer Science|July 9, 2016
Podoplanin associates with adverse postoperative prognosis of patients with clear cell renal cell carcinomaYu Xia, Li Liu, Ying Xiong, et al.Cancer Science|July 27, 2017
Regulation of spindle and kinetochore-associated protein 1 by antitumor miR-10a-5p in renal cell carcinomaTakayuki Arai, Atsushi Okato, Satoko Kojima, et al.Cancer Science|July 27, 2017
Overexpression of leucine-rich α2-glycoprotein-1 is a prognostic marker and enhances tumor migration in gastric cancerMasaaki Yamamoto, Tsuyoshi Takahashi, Satoshi Serada, et al.Cancer Science|August 2, 2017
Tumor endothelial cells accelerate tumor metastasisNako Maishi, Kyoko HidaCancer Science|August 9, 2017
Contrasting effects of cyclophosphamide on anti-CTL-associated protein 4 blockade therapy in two mouse tumor modelsYuichi Iida, Nanae Harashima, Takanobu Motoshima, et al.Pageof 700